Literature DB >> 16954403

Random mutagenesis of Helicobacter pylori vacA to identify amino acids essential for vacuolating cytotoxic activity.

Mark S McClain1, Daniel M Czajkowsky, Victor J Torres, Gabor Szabo, Zhifeng Shao, Timothy L Cover.   

Abstract

VacA is a secreted toxin that plays a role in Helicobacter pylori colonization of the stomach and may contribute to the pathogenesis of peptic ulcer disease and gastric cancer. In this study, we analyzed a library of plasmids expressing randomly mutated forms of recombinant VacA and identified 10 mutant VacA proteins that lacked vacuolating cytotoxic activity when added to HeLa cells. The mutations included six single amino acid substitutions within an amino-terminal hydrophobic region and four substitutions outside the amino-terminal hydrophobic region. All 10 mutations mapped within the p33 domain of VacA. By introducing mutations into the H. pylori chromosomal vacA gene, we showed that secreted mutant toxins containing V21L, S25L, G121R, or S246L mutations bound to cells and were internalized but had defects in vacuolating activity. In planar lipid bilayer and membrane depolarization assays, VacA proteins containing V21L and S25L mutations were defective in formation of anion-selective membrane channels, whereas proteins containing G121R or S246L mutations retained channel-forming capacity. These are the first point mutations outside the amino-terminal hydrophobic region that are known to abrogate vacuolating toxin activity. In addition, these are the first examples of mutant VacA proteins that have defects in vacuolating activity despite exhibiting channel activities similar to those of wild-type VacA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954403      PMCID: PMC1695532          DOI: 10.1128/IAI.00915-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Mutational analysis of the Helicobacter pylori vacuolating toxin amino terminus: identification of amino acids essential for cellular vacuolation.

Authors:  D Ye; S R Blanke
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin.

Authors:  V Q Nguyen; R M Caprioli; T L Cover
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Amino-terminal hydrophobic region of Helicobacter pylori vacuolating cytotoxin (VacA) mediates transmembrane protein dimerization.

Authors:  M S McClain; P Cao; T L Cover
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Expression and binding analysis of GST-VacA fusions reveals that the C-terminal approximately 100-residue segment of exotoxin is crucial for binding in HeLa cells.

Authors:  H J Wang; W C Wang
Journal:  Biochem Biophys Res Commun       Date:  2000-11-19       Impact factor: 3.575

5.  Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta.

Authors:  K Yahiro; T Niidome; M Kimura; T Hatakeyama; H Aoyagi; H Kurazono; K i Imagawa; A Wada; J Moss; T Hirayama
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

6.  Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection.

Authors:  N R Salama; G Otto; L Tompkins; S Falkow
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Antigenic diversity among Helicobacter pylori vacuolating toxins.

Authors:  A D Vinion-Dubiel; M S McClain; P Cao; R L Mernaugh; T L Cover
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

8.  Outer membrane targeting of passenger proteins by the vacuolating cytotoxin autotransporter of Helicobacter pylori.

Authors:  W Fischer; R Buhrdorf; E Gerland; R Haas
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

9.  A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation.

Authors:  M S McClain; P Cao; H Iwamoto; A D Vinion-Dubiel; G Szabo; Z Shao; T L Cover
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

10.  A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation.

Authors:  A D Vinion-Dubiel; M S McClain; D M Czajkowsky; H Iwamoto; D Ye; P Cao; W Schraw; G Szabo; S R Blanke; Z Shao; T L Cover
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

View more
  8 in total

1.  Analysis of a beta-helical region in the p55 domain of Helicobacter pylori vacuolating toxin.

Authors:  Susan E Ivie; Mark S McClain; Holly M Scott Algood; D Borden Lacy; Timothy L Cover
Journal:  BMC Microbiol       Date:  2010-02-23       Impact factor: 3.605

2.  Screening for transmembrane association in divisome proteins using TOXGREEN, a high-throughput variant of the TOXCAT assay.

Authors:  Claire R Armstrong; Alessandro Senes
Journal:  Biochim Biophys Acta       Date:  2016-07-22

3.  Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes.

Authors:  Susan E Ivie; Mark S McClain; Victor J Torres; Holly M Scott Algood; D Borden Lacy; Rong Yang; Steven R Blanke; Timothy L Cover
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

4.  The intermediate region of Helicobacter pylori VacA is a determinant of toxin potency in a Jurkat T cell assay.

Authors:  Christian González-Rivera; Holly M Scott Algood; Jana N Radin; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2012-05-14       Impact factor: 3.441

5.  A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain.

Authors:  Christian González-Rivera; Anne M Campbell; Stacey A Rutherford; Tasia M Pyburn; Nora J Foegeding; Theresa L Barke; Benjamin W Spiller; Mark S McClain; Melanie D Ohi; D Borden Lacy; Timothy L Cover
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

6.  H. pylori Infection and Virulence Factors cagA and vacA (s and m Regions) in Gastric Adenocarcinoma from Pará State, Brazil.

Authors:  Igor Brasil-Costa; Cintya de Oliveira Souza; Leni Célia Reis Monteiro; Maria Elisabete Silva Santos; Edivaldo Herculano Correa De Oliveira; Rommel Mario Rodriguez Burbano
Journal:  Pathogens       Date:  2022-03-29

Review 7.  An Overview of Helicobacter pylori VacA Toxin Biology.

Authors:  Nora J Foegeding; Rhonda R Caston; Mark S McClain; Melanie D Ohi; Timothy L Cover
Journal:  Toxins (Basel)       Date:  2016-06-03       Impact factor: 4.546

Review 8.  Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy.

Authors:  Farnaz Fahimi; Mohammad Reza Tohidkia; Mehdi Fouladi; Reza Aghabeygi; Naser Samadi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2017-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.